1111 - 1120 of 6570 Results
Title
Year
-
OPENTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3589103Citation Count: 47
-
OPENTitle: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 18Start Page: eaba1193End Page: eaba1193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aba1193Best OA location URL: https://advances.sciencemag.org/content/advances/6/18/eaba1193.full.pdfCitation Count: 70
-
OPENTitle: GP2: The Global Parkinson's Genetics ProgramJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 842End Page: 851Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28494Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28494Citation Count: 168
-
OPENTitle: A unifying model for the role of the ATG8 system in autophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 135Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/jcs.258997Best OA location URL: https://doi.org/10.1242/jcs.258997Citation Count: 28
-
OPENTitle: The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy modelsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 123Issue #: 12Start Page: e2517886123End Page: e2517886123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2517886123Best OA location URL: https://doi.org/10.1073/pnas.2517886123Citation Count: 0
-
OPENTitle: Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 201End Page: 209Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8978879Citation Count: 22
-
OPENTitle: Deep learning-derived arterial input function for dynamic brain PETJournal Name: NeuroImagePublisher: Elsevier BVVol: 324Issue #:Start Page: 121609End Page: 121609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2025.121609Best OA location URL: https://doi.org/10.1016/j.neuroimage.2025.121609Citation Count: 2
-
OPENTitle: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 4Start Page: 479End Page: 483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13451Citation Count: 29
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 7Start Page: 1253End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://doi.org/10.1177/1877718x251356503Citation Count: 2
-
OPENTitle: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 724End Page: 735Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133481Citation Count: 126